Friday 6 November 2026
Export IQV’s income statement to Excel — free account
IQVIA Holdings Inc.
IQV Healthcare Diagnostics & Research
IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.
- Revenue
- +8.00%
- EPS
- +10.2%
- Free cash flow
- −21.3%
- Total debt
- +7.42%
Quarter to September 2026, against a year earlier
271.36
6.48
+2.45%
Follow IQV
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | 7 | 5 | 4 |
+8 more TTM periods Free account |
| 21.32% | 22.75% | 22.46% | 21.42% | ||
| 4.71% | 4.70% | 4.86% | 4.79% | ||
ROIC |
6.79% | 6.80% | 6.85% | 6.75% | |
Return on Tangible Assets |
(176.01%) | (67.34%) | (86.94%) | (87.40%) | |
Average Days of Receivables |
70.25 | 72.79 | 74.07 | 76.69 | |
Free Cash Flow per Share |
12.62 | 13.60 | 13.01 | 12.37 | |
Free Cash Flow |
2,079.00 | 2,259.00 | 2,191.00 | 2,126.00 | |
Capital Expenditures |
(657.00) | (560.00) | (513.00) | (528.00) | |
| Other line items | |||||
Cash ROIC |
8.22% | 9.27% | 9.02% | 8.68% | |
Accounts Receivable Turnover |
5.21 | 5.00 | 4.98 | 4.89 | |
Accounts Payable Turnover |
3.21 | 3.25 | 3.10 | 2.93 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
115.80 | 115.68 | 119.18 | 125.84 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.16) | (0.16) | (0.16) | (0.16) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.21% | 12.12% | 11.98% | 12.26% | |
Share Based Compensation of Revenue |
1.75% | 1.62% | 1.44% | 1.51% | |
Interest Coverage |
2.83 | 2.85 | 2.91 | 2.99 | |
Operating CF/Net income |
1.96 | 2.05 | 1.95 | 1.95 | |
Depreciation/Fixed assets |
2.32 | 2.21 | 2.31 | 2.19 | |
Capex/Depreciation |
(0.53) | (0.46) | (0.43) | (0.45) | |
Revenue per Share |
105.11 | 102.25 | 98.76 | 94.88 | |
Operating CF per Share |
16.61 | 16.97 | 16.06 | 15.44 | |
Capex per Share |
(3.99) | (3.37) | (3.05) | (3.07) | |
Capex to Sales |
0.04 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 2 Nov 2026